![[TXT]](/icons/text.gif) 121b.0911-Screening for subclinical CAD measuring cIMT (Nguyen-Thanh, Am J Cardiol)_s.pdf | 140.34Kb | November 12 2009 |
| 132.0911-Reappraisal of European guidelines on HTA management (ESH, J Hypertens)_s.pdf | 885.70Kb | November 11 2009 |
| 132.0911-Retinal arterial narrowing as marker of renal dysfunction (Cuspidi, J Hypertens)_s.pdf | 239.60Kb | November 11 2009 |
| 136.0911-Slow walking and CV death in well functioning older adults (Dumurgier, bmj)_s.pdf | 146.94Kb | November 12 2009 |
| 141.0911-Aspirin for Iary prevention of CV events in people with diabetes. MA of RCT (De Berardis, bmj)_s.pdf | 142.21Kb | November 10 2009 |
| 222.0912-Extending the time window for thrombolytic therapy, primum non tardare (Lyden, Lancet Neurol)_s.pdf | 162.56Kb | November 12 2009 |
| 223.0912-CT & CTA predict functional impairment in patients with minor stroke & TIA (Coutts, Int J Stroke)_s.pdf | 171.56Kb | November 7 2009 |
| 255.0910ep-CEA vs carotid angioplasty, Cui Bono (Moore, ejves)_s.pdf | 130.95Kb | November 12 2009 |
| 255.0912-Carotid PTA and stenting, will it ever replace CEA (Chambers, Int J Stroke)_s.pdf | 52.97Kb | November 7 2009 |
| 276.0911-Clinical and Radiological natural history of CAD (Schwartz, Int J Stroke & CVD)_s.pdf | 317.97Kb | November 12 2009 |
| 311.0911-ABI for assessment of PAD (Grenon, nejm)_s.pdf | 126.82Kb | November 11 2009 |
| 350.0911-Renal artery stenosis (Dworkin, nejm)_s.pdf | 430.38Kb | November 12 2009 |
| 352.0911-Revascularization vs Medical therapy for RAS (ASTRAL investigators, nejm)_s.pdf | 475.96Kb | November 12 2009 |
| 373d.0911-A 66 yr old man with AAA (Schermerhorn, jama)_s.pdf | 396.69Kb | November 11 2009 |
| 373d.0911-Screening for AAA with electronic clinical reminders (Padberg, Am J Surg)_s.pdf | 271.02Kb | November 12 2009 |
| 418.0911-Tt of bilateral hand frostbite using catheter arterial thrombolysis (Saemi, CVIR)_s.pdf | 228.19Kb | November 11 2009 |
| 53.0911-Using probabilistic reasoning (Doust, bmj)_s.pdf | 324.28Kb | November 12 2009 |
| 611.0911-Anthropometry, Body fat, and VTE. A Danish FU study (Severinsen, Circulation)_s.pdf | 330.95Kb | November 11 2009 |
| 611.0911-Incidence rates, clinical profile, and outcomes of patients with VTE. WORCESTER (Spencer, JTT)_s.pdf | 246.90Kb | November 12 2009 |
| 620.0911-Physician alert to prevent VTE (Piazza, JTT)_s.pdf | 191.28Kb | November 12 2009 |
| 635.0911-DD to determine AC duration, CV events and occult Kc risk after a 1st idiopathic VTE. PROLONG (Cosmi, JTT)_s.pdf | 188.40Kb | November 12 2009 |
| 635b.0,93-D-dimer with clinically suspected PE (Ginsberg, Chest)_s.pdf | 1.25Mb | November 11 2009 |
| 645.0911-Lipoma causing UE DVT, Case report (Palamari, JTT)_s.pdf | 158.42Kb | November 12 2009 |
| 648.0911-PE, another piece of the puzzle (Elliot, Chest)_s.pdf | 359.28Kb | November 12 2009 |
| 649.0911-Evaluation of R ventricular function and functional status 6 months after submassive PE (Kline, Chest)_s.pdf | 585.35Kb | November 11 2009 |
| 653.0910-Nadroparine for VTE prevention in ambulatory patients with solid Kc & chimiotherapy (PROTECHT Lancet Oncol)_s.pdf | 168.27Kb | November 12 2009 |
| 675.0911-Attitudes to prescribing GCS for patients with acute DVT, MASTER Registry (Arpaia, JTT)_s.pdf | 165.82Kb | November 12 2009 |
| 72.0912-New antiplatelet agents, why they are needed (Franchini, Eur J Intern Med)_s.pdf | 303.42Kb | November 12 2009 |
| 73.0910ep-Newer anticoagulants in 2009 (Samama, JTT)_s.pdf | 308.00Kb | November 12 2009 |
| 73.0911ep-New oral anticoagulants, a pratical guide to physicians (Wittkowsky, JTT)_s.pdf | 169.04Kb | November 11 2009 |
![[DIR]](/icons/back.gif){kind=icon}
Parent Directory